XRTX

Conviction 47Scan · Fri, Oct 9, 2026

XORTX Therapeutics Inc. (XRTX) closed at $1.41 (-23.78%) on Oct 9, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 34, RS Rating 99, -53.5% from its 52-week high, +147.4% year to date.

XRTX$1.41-23.78%

ResistanceSupportVol 14

Vol MA14 2.13M

Jul 14Jul 30Aug 18Sep 3Sep 23Oct 9

XORTX Therapeutics Inc.www.xortx.com ↗

Price1.41

Change-23.78%

Gap+10.81%

Rel volume3.51×

Avg volume1.26M

Avg $ vol2.25M

SMA 201.76

SMA 502.01

SMA 2001.60

Price vs 50-29.88%

Price vs 200-11.91%

MA stackmixed

50/200 cross—

Supertrenddown · 2.14

RSI (14)34

MACD hist-0.01

MACD crossbear · 0d

Stoch %K / %D6 / 17

ADX (14)27

+DI / −DI25 / 24

RSI divergence—

MACD divergence—

ATR %14.11%

ADR %11.09%

52w high3.03

52w low0.3450

From 52w high-53.47%

Above 52w low+308.70%

New 52w highNo

SqueezeOn · 1d

Bollinger width30.14%

%B-0.16

Donchian pos3.12%

Donchian high2.65

Donchian low1.37

AVWAP (52w high)2.65

vs AVWAP high-46.72%

AVWAP (52w low)2.63

vs AVWAP low-46.36%

OBV trendUp

Chaikin MF (20)-0.16

Today vs 20d3.51×

Avg vol (14d)1.08M

Avg vol (20d)1.26M

Avg $ vol (20d)2.25M

Market cap2.44M

RS Rating99 / 99

RS 3m (vs SPY)-34.46%

RS 6m (vs SPY)-57.95%

RS line new highNo

Trend template4/8

Technical rank12.8

1 week-17.75%

1 month-33.18%

3 months-30.54%

6 months-43.37%

1 year+57.82%

YTD+147.37%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.44M

Revenue—

Net income—

Gross profit—

Free cash flow—

Industry—

ExchangeNasdaq

Shares out1.73M

Employees3

ListedFri, May 4, 2018

Free float6.82M

Float %98.0%

Short interest14.63K

Days to cover1.3d

Short volume56.0%

Squeeze score33 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction47 / 100

Pattern quality—

Tech rank12.8 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.65

Support1.64

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in XRTX

All disclosures →

No recent disclosed trades by Congress in XRTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XRTX

No recent insider (Form 4) filings in XRTX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in XRTX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

XRTX

Recent news

Get daily signals & real-time alerts.